Tari A. King
Brigham and Women's Hospital(US)Harvard University(US)Emory University(US)University of Calgary(CA)University of Utah(US)Dana-Farber Cancer Institute(US)Dana-Farber/Harvard Cancer Center(US)Dana-Farber Brigham Cancer Center(US)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Breast Lesions and Carcinomas, Cancer Genomics and Diagnostics, HER2/EGFR in Cancer Research, BRCA gene mutations in cancer
Most-Cited Works
- → Tumour exosome integrins determine organotropic metastasis(2015)4,961 cited
- → Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer(2015)1,925 cited
- → ESR1 ligand-binding domain mutations in hormone-resistant breast cancer(2013)1,235 cited
- → HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures(2017)1,112 cited
- → Tumor Entrained Neutrophils Inhibit Seeding in the Premetastatic Lung(2011)770 cited
- → Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for Tis,1,2 breast cancer(2000)401 cited